Related references
Note: Only part of the references are listed.Replication-Competent Retroviruses in Gene-Modified T Cells Used in Clinical Trials: Is It Time to Revise the Testing Requirements?
Adham S. Bear et al.
MOLECULAR THERAPY (2012)
Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection
Alessandra Biffi et al.
BLOOD (2011)
Effect of the Internal Promoter on Insertional Gene Activation by Lentiviral Vectors with an Intact HIV Long Terminal Repeat
Sean Knight et al.
JOURNAL OF VIROLOGY (2010)
State-of-the-Art Lentiviral Vectors for Research Use: Risk Assessment and Biosafety Recommendations
Katia Pauwels et al.
CURRENT GENE THERAPY (2009)
Analysis of Lentiviral Vector Integration in HIV plus Study Subjects Receiving Autologous Infusions of Gene Modified CD4+T Cells
Gary P. Wang et al.
MOLECULAR THERAPY (2009)
Gene transfer in humans using a conditionally replicating lentiviral vector
Bruce L. Levine et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration
Eugenio Montini et al.
NATURE BIOTECHNOLOGY (2006)
Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors
C Baum et al.
HUMAN GENE THERAPY (2006)
Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells
P Hematti et al.
PLOS BIOLOGY (2004)
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1
S Hacein-Bey-Abina et al.
SCIENCE (2003)
A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency
S Hacein-Bey-Abina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
